Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 6 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 03, 2023 Filed Jan 6, 2023 01:00 UTC |
COLLIER EARL M JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 37,770 | $0.00 Strike: $3.85 | $0.00 |
DisclosureSEC source: 0001415889-23-000593 · form4-01052023_080132.xml · derivative · entry 1 COLLIER EARL M JR · CIK 0001201254 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,770 Underlying: Common Stock · 37,770 shares Expires 2033-01-03 F1 · derivative.exercise_date: The shares vest 1/12th of the first day of each month, commencing February 1, 2023, with the last month vesting on December 31, 2023, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 01:00 UTC |
Marban LindaDirector · CHIEF EXECUTIVE OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 135,000 | $0.00 Strike: $3.85 | $0.00 |
DisclosureSEC source: 0001415889-23-000591 · form4-01052023_080115.xml · derivative · entry 1 Marban Linda · CIK 0001593084 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Underlying: Common Stock · 135,000 shares Expires 2033-01-03 F1 · derivative.exercise_date: The shares vest 1/48th of the first day of each month, commencing February 1, 2023, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 01:00 UTC |
Krasney KarenEVP, GENERAL COUNSEL
|
GrantStock Option (Right to Buy) · Derivative | 11,878 | $0.00 Strike: $3.85 | $0.00 |
DisclosureSEC source: 0001415889-23-000590 · form4-01052023_080107.xml · derivative · entry 2 Krasney Karen · CIK 0001593086 · EVP, GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,878 Underlying: Common Stock · 11,878 shares Expires 2033-01-03 F2 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 3, 2023, the date of the grant. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 01:00 UTC |
Krasney KarenEVP, GENERAL COUNSEL
|
GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $3.85 | $0.00 |
DisclosureSEC source: 0001415889-23-000590 · form4-01052023_080107.xml · derivative · entry 1 Krasney Karen · CIK 0001593086 · EVP, GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2033-01-03 F1 · derivative.exercise_date: The shares vest 1/48th of the first day of each month, commencing February 1, 2023, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 01:00 UTC |
Bergmann AnthonyCHIEF FINANCIAL OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 85,000 | $0.00 Strike: $3.85 | $0.00 |
DisclosureSEC source: 0001415889-23-000589 · form4-01052023_080101.xml · derivative · entry 1 Bergmann Anthony · CIK 0001593087 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2033-01-03 F1 · derivative.exercise_date: The shares vest 1/48th of the first day of each month, commencing February 1, 2023, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 22:00 UTC Amendment |
Sabar Karimah EsDirector
|
GrantStock Option (Right to Buy) · Derivative | 3,560 | $0.00 Strike: $3.85 | $0.00 |
DisclosureSEC source: 0001415889-23-000634 · form4a-01062023_050101.xml · derivative · entry 1 Sabar Karimah Es · CIK 0001873796 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,560 Underlying: Common Stock · 3,560 shares Expires 2033-01-03 F1 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 3, 2023, the date of the grant. Read SEC document |
| November 03, 2022 Filed Nov 4, 2022 13:25 UTC |
Krasney KarenEVP, GENERAL COUNSEL
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 18,932 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001415889-22-011079 · form4-11042022_091102.xml · derivative · entry 2 Krasney Karen · CIK 0001593086 · EVP, GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,932 shares Expires 2022-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: This option was granted on November 13, 2012 and was previously reported as covering 189,320 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. F2 · derivative.exercise_date: 25% of the shares vested immediately, with the remainder vesting 1/36th on the first day of each month commencing December 1, 2012. F1 · derivative.underlying_shares: This option was granted on November 13, 2012 and was previously reported as covering 189,320 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. Read SEC document |
| November 03, 2022 Filed Nov 4, 2022 13:25 UTC |
Krasney KarenEVP, GENERAL COUNSEL
|
Exercise / conversionCommon Stock | 18,932 | $1.39 | $26,315.48 |
DisclosureSEC source: 0001415889-22-011079 · form4-11042022_091102.xml · nonDerivative · entry 1 Krasney Karen · CIK 0001593086 · EVP, GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,047 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 21:31 UTC |
Avat XavierCHIEF BUSINESS OFFICER
|
PurchaseCommon Stock | 1,000 | $3.68 | $3,680.00 |
DisclosureSEC source: 0001415889-22-007544 · form4-07072022_020749.xml · nonDerivative · entry 2 Avat Xavier · CIK 0001931345 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Read SEC document |
| June 30, 2022 Filed Jul 2, 2022 01:00 UTC |
Musket David BDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,645 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001415889-22-007219 · form4-07012022_090701.xml · derivative · entry 6 Musket David B · CIK 0001310611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,645 shares Expires 2026-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: This option was granted on June 2, 2016 and was previously reported as covering 46,458 shares at an exercise price of $3.12 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. F6 · derivative.exercise_date: 2,250 shares vested immediately on June 2, 2016. The remaining shares vested on December 31, 2016. F5 · derivative.underlying_shares: This option was granted on June 2, 2016 and was previously reported as covering 46,458 shares at an exercise price of $3.12 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. Read SEC document |
| June 30, 2022 Filed Jul 2, 2022 01:00 UTC |
Musket David BDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,750 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001415889-22-007219 · form4-07012022_090701.xml · derivative · entry 5 Musket David B · CIK 0001310611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,750 shares Expires 2025-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: This option was granted on March 3, 2015 and was previously reported as covering 47,500 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. F4 · derivative.underlying_shares: This option was granted on March 3, 2015 and was previously reported as covering 47,500 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. Read SEC document |
| June 30, 2022 Filed Jul 2, 2022 01:00 UTC |
Musket David BDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,401 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001415889-22-007219 · form4-07012022_090701.xml · derivative · entry 4 Musket David B · CIK 0001310611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,401 shares Expires 2023-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: This option was granted on February 22, 2013 and was previously reported as covering 14,015 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. F3 · derivative.exercise_date: 25% of the shares of common stock vested immediately, with the remainder vesting 1/36th of the first day of each month, commencing May 1, 2013. F2 · derivative.underlying_shares: This option was granted on February 22, 2013 and was previously reported as covering 14,015 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. Read SEC document |
| June 30, 2022 Filed Jul 2, 2022 01:00 UTC |
Musket David BDirector
|
Exercise / conversionCommon Stock | 10,796 | $1.39 | $15,006.44 |
DisclosureSEC source: 0001415889-22-007219 · form4-07012022_090701.xml · nonDerivative · entry 2 Musket David B · CIK 0001310611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,543 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 29, 2022 Filed Jul 2, 2022 01:00 UTC |
Musket David BDirector
|
SaleCommon Stock | 28,215 | $3.77 | $106,370.55 |
DisclosureSEC source: 0001415889-22-007219 · form4-07012022_090701.xml · nonDerivative · entry 1 Musket David B · CIK 0001310611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,747 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.76 to $3.80, inclusive. The reporting person undertakes to provide to Capricor Therapeutics, Inc., any security holder of Capricor Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 29, 2022 Filed Jul 7, 2022 21:31 UTC |
Avat XavierCHIEF BUSINESS OFFICER
|
PurchaseCommon Stock | 1,500 | $3.76 | $5,642.85 |
DisclosureSEC source: 0001415889-22-007544 · form4-07072022_020749.xml · nonDerivative · entry 1 Avat Xavier · CIK 0001931345 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Read SEC document |
| June 27, 2022 Filed Jun 30, 2022 01:00 UTC |
Musket David BDirector
|
SaleCommon Stock | 17,775 | $4.44 | $78,921.00 |
DisclosureSEC source: 0001415889-22-007064 · form4-06292022_090601.xml · nonDerivative · entry 1 Musket David B · CIK 0001310611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,962 F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to partially cover tax obligations in connection to stock holdings. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.41 to $4.46, inclusive. The reporting person undertakes to provide to Capricor Therapeutics, Inc., any security holder of Capricor Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 23, 2022 Filed May 27, 2022 01:33 UTC |
Avat XavierCHIEF BUSINESS OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 370,000 | $0.00 Strike: $3.46 | $0.00 |
DisclosureSEC source: 0001415889-22-005749 · form4-05262022_060515.xml · derivative · entry 1 Avat Xavier · CIK 0001931345 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 370,000 Underlying: Common Stock · 370,000 shares Expires 2032-05-23 F1 · derivative.exercise_date: The shares vest 1/48th of the first day of each month, commencing June 1, 2022, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 21:00 UTC |
Manzo LouisDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,449 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001415889-22-003580 · form4-04012022_050408.xml · derivative · entry 4 Manzo Louis · CIK 0001593100 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,449 shares Expires 2022-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: This option was granted on April 27, 2012 and was previously reported as covering 124,491 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. F5 · derivative.exercise_date: The shares vested immediately. F4 · derivative.underlying_shares: This option was granted on April 27, 2012 and was previously reported as covering 124,491 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 21:00 UTC |
Manzo LouisDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,455 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001415889-22-003580 · form4-04012022_050408.xml · derivative · entry 3 Manzo Louis · CIK 0001593100 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,455 shares Expires 2022-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: This option was granted on April 27, 2012 and was previously reported as covering 154,555 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. F3 · derivative.exercise_date: The shares vested 1/48th of the first day of each month, commencing May 1, 2012. F2 · derivative.underlying_shares: This option was granted on April 27, 2012 and was previously reported as covering 154,555 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 21:00 UTC |
Manzo LouisDirector
|
Tax withholdingCommon Stock | 11,309 | $3.43 | $38,789.87 |
DisclosureSEC source: 0001415889-22-003580 · form4-04012022_050408.xml · nonDerivative · entry 2 Manzo Louis · CIK 0001593100 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,595 F1 · kind: Represents a "net exercise" of outstanding stock options. These shares were withheld by the Issuer for payment of the exercise price, based on the closing market price of the Issuer's common stock on March 31, 2022 of $3.43. The options would otherwise expire on April 27, 2022, pursuant to their terms. F1 · price: Represents a "net exercise" of outstanding stock options. These shares were withheld by the Issuer for payment of the exercise price, based on the closing market price of the Issuer's common stock on March 31, 2022 of $3.43. The options would otherwise expire on April 27, 2022, pursuant to their terms. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 21:00 UTC |
Manzo LouisDirector
|
Exercise / conversionCommon Stock | 27,904 | $1.39 | $38,786.56 |
DisclosureSEC source: 0001415889-22-003580 · form4-04012022_050408.xml · nonDerivative · entry 1 Manzo Louis · CIK 0001593100 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,904 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2022 Filed Mar 31, 2022 21:00 UTC |
DUNBAR GEORGE W JRDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,455 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001415889-22-003514 · form4-03312022_050302.xml · derivative · entry 3 DUNBAR GEORGE W JR · CIK 0001194712 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,455 shares Expires 2022-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: This option was granted on April 27, 2012 and was previously reported as covering 154,555 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. F3 · derivative.exercise_date: The shares vested 1/48th of the first day of each month, commencing May 1, 2012. F2 · derivative.underlying_shares: This option was granted on April 27, 2012 and was previously reported as covering 154,555 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. Read SEC document |
| March 29, 2022 Filed Mar 31, 2022 21:00 UTC |
DUNBAR GEORGE W JRDirector
|
Tax withholdingCommon Stock | 6,300 | $3.41 | $21,483.00 |
DisclosureSEC source: 0001415889-22-003514 · form4-03312022_050302.xml · nonDerivative · entry 2 DUNBAR GEORGE W JR · CIK 0001194712 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,155 F1 · kind: Represents a "net exercise" of outstanding stock options. These shares were withheld by the Issuer for payment of the exercise price, based on the closing market price of the Issuer's common stock on March 29, 2022 of $3.41. The options would otherwise expire on April 27, 2022, pursuant to their terms. F1 · price: Represents a "net exercise" of outstanding stock options. These shares were withheld by the Issuer for payment of the exercise price, based on the closing market price of the Issuer's common stock on March 29, 2022 of $3.41. The options would otherwise expire on April 27, 2022, pursuant to their terms. Read SEC document |
| March 29, 2022 Filed Mar 31, 2022 21:00 UTC |
DUNBAR GEORGE W JRDirector
|
Exercise / conversionCommon Stock | 15,455 | $1.39 | $21,482.45 |
DisclosureSEC source: 0001415889-22-003514 · form4-03312022_050302.xml · nonDerivative · entry 1 DUNBAR GEORGE W JR · CIK 0001194712 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 00:00 UTC |
COLLIER EARL M JRDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,455 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001415889-22-002812 · form4-03092022_070302.xml · derivative · entry 2 COLLIER EARL M JR · CIK 0001201254 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,455 shares Expires 2022-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: This option was granted on April 27, 2012 and was previously reported as covering 154,555 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. F2 · derivative.exercise_date: 25% of the shares vested immediately, with the remainder vesting 1/36th of the first day of each month commencing June 1, 2012. F1 · derivative.underlying_shares: This option was granted on April 27, 2012 and was previously reported as covering 154,555 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 00:00 UTC |
COLLIER EARL M JRDirector
|
Exercise / conversionCommon Stock | 15,455 | $1.39 | $21,482.45 |
DisclosureSEC source: 0001415889-22-002812 · form4-03092022_070302.xml · nonDerivative · entry 1 COLLIER EARL M JR · CIK 0001201254 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 02:00 UTC |
Sabar Karimah EsDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,690 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0001415889-22-000283 · form4-01042022_090148.xml · derivative · entry 1 Sabar Karimah Es · CIK 0001873796 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,690 Underlying: Common Stock · 7,690 shares Expires 2032-01-03 F1 · derivative.exercise_date: The shares vest 1/48th of the first day of each month, commencing February 1, 2022, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 02:01 UTC |
Litvack FrankDirector
|
GrantStock Option (Right to Buy) · Derivative | 252,250 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0001415889-22-000284 · form4-01042022_090154.xml · derivative · entry 4 Litvack Frank · CIK 0001310715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,250 Underlying: Common Stock · 252,250 shares Expires 2032-01-03 F3 · derivative.exercise_date: The shares vest 1/48th of the first day of each month, commencing February 1, 2022, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 02:01 UTC |
Litvack FrankDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 154,543 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001415889-22-000284 · form4-01042022_090154.xml · derivative · entry 3 Litvack Frank · CIK 0001310715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 154,543 shares Expires 2022-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted on April 27, 2012 and was previously reported as covering 1,545,435 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 02:01 UTC |
Litvack FrankDirector
|
Tax withholdingCommon Stock | 67,552 | $3.18 | $214,815.36 |
DisclosureSEC source: 0001415889-22-000284 · form4-01042022_090154.xml · nonDerivative · entry 2 Litvack Frank · CIK 0001310715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,382 F1 · kind: Represents a "net exercise" of outstanding stock options. These shares were withheld by the Issuer for payment of the exercise price, based on the closing market price of the Issuer's common stock on January 3, 2022 of $3.18. The options would otherwise expire on April 27, 2022, pursuant to their terms. F1 · price: Represents a "net exercise" of outstanding stock options. These shares were withheld by the Issuer for payment of the exercise price, based on the closing market price of the Issuer's common stock on January 3, 2022 of $3.18. The options would otherwise expire on April 27, 2022, pursuant to their terms. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 02:01 UTC |
Litvack FrankDirector
|
Exercise / conversionCommon Stock | 154,543 | $1.39 | $214,814.77 |
DisclosureSEC source: 0001415889-22-000284 · form4-01042022_090154.xml · nonDerivative · entry 1 Litvack Frank · CIK 0001310715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,934 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 02:00 UTC |
Musket David BDirector
|
GrantStock Option (Right to Buy) · Derivative | 84,080 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0001415889-22-000281 · form4-01042022_090140.xml · derivative · entry 1 Musket David B · CIK 0001310611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,080 Underlying: Common Stock · 84,080 shares Expires 2032-01-03 F1 · derivative.exercise_date: The shares vest 1/48th of the first day of each month, commencing February 1, 2022, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 02:00 UTC |
Manzo LouisDirector
|
GrantStock Option (Right to Buy) · Derivative | 83,590 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0001415889-22-000280 · form4-01042022_090134.xml · derivative · entry 1 Manzo Louis · CIK 0001593100 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,590 Underlying: Common Stock · 83,590 shares Expires 2032-01-03 F1 · derivative.exercise_date: The shares vest 1/48th of the first day of each month, commencing February 1, 2022, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 02:00 UTC |
COLLIER EARL M JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 63,060 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0001415889-22-000278 · form4-01042022_090129.xml · derivative · entry 1 COLLIER EARL M JR · CIK 0001201254 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,060 Underlying: Common Stock · 63,060 shares Expires 2032-01-03 F1 · derivative.exercise_date: The shares vest 1/48th of the first day of each month, commencing February 1, 2022, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 02:00 UTC |
DUNBAR GEORGE W JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 63,060 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0001415889-22-000277 · form4-01042022_090123.xml · derivative · entry 1 DUNBAR GEORGE W JR · CIK 0001194712 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,060 Underlying: Common Stock · 63,060 shares Expires 2032-01-03 F1 · derivative.exercise_date: The shares vest 1/48th of the first day of each month, commencing February 1, 2022, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 02:00 UTC |
Marban LindaDirector · CHIEF EXECUTIVE OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 377,830 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0001415889-22-000274 · form4-01042022_090105.xml · derivative · entry 1 Marban Linda · CIK 0001593084 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 377,830 Underlying: Common Stock · 377,830 shares Expires 2032-01-03 F1 · derivative.exercise_date: The shares vest 1/48th of the first day of each month, commencing February 1, 2022, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 02:00 UTC |
Bergmann AnthonyCHIEF FINANCIAL OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 166,980 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0001415889-22-000276 · form4-01042022_090117.xml · derivative · entry 1 Bergmann Anthony · CIK 0001593087 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,980 Underlying: Common Stock · 166,980 shares Expires 2032-01-03 F1 · derivative.exercise_date: The shares vest 1/48th of the first day of each month, commencing February 1, 2022, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 02:00 UTC |
Krasney KarenEVP, GENERAL COUNSEL
|
GrantStock Option (Right to Buy) · Derivative | 84,080 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0001415889-22-000275 · form4-01042022_090112.xml · derivative · entry 1 Krasney Karen · CIK 0001593086 · EVP, GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,080 Underlying: Common Stock · 84,080 shares Expires 2032-01-03 F1 · derivative.exercise_date: The shares vest 1/48th of the first day of each month, commencing February 1, 2022, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 14:00 UTC |
Musket David BDirector
|
Exercise / conversionWarrants (Right to Buy) · Derivative | 20,391 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0001415889-21-006268 · form4-12292021_091205.xml · derivative · entry 5 Musket David B · CIK 0001310611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,391 shares Expires 2024-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 14:00 UTC |
Musket David BDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,455 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001415889-21-006268 · form4-12292021_091205.xml · derivative · entry 4 Musket David B · CIK 0001310611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,455 shares Expires 2022-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: This option was granted on April 27, 2012 and was previously reported as covering 154,555 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. F2 · derivative.exercise_date: The shares vested 1/48th of the first day of each month, commencing May 1, 2012. F1 · derivative.underlying_shares: This option was granted on April 27, 2012 and was previously reported as covering 154,555 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 14:00 UTC |
Musket David BDirector
|
Exercise / conversionCommon Stock | 20,391 | $1.10 | $22,430.10 |
DisclosureSEC source: 0001415889-21-006268 · form4-12292021_091205.xml · nonDerivative · entry 2 Musket David B · CIK 0001310611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,737 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 14:00 UTC |
Musket David BDirector
|
Exercise / conversionCommon Stock | 15,455 | $1.39 | $21,482.45 |
DisclosureSEC source: 0001415889-21-006268 · form4-12292021_091205.xml · nonDerivative · entry 1 Musket David B · CIK 0001310611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 23, 2021 Filed Jul 27, 2021 22:31 UTC |
Sabar Karimah EsDirector
|
GrantStock Option (Right to Buy) · Derivative | 115,000 | $0.00 Strike: $4.86 | $0.00 |
DisclosureSEC source: 0001104659-21-096408 · tm2123420-1_4seq1.xml · derivative · entry 1 Sabar Karimah Es · CIK 0001873796 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,000 Underlying: Common Stock · 115,000 shares Expires 2031-07-23 F1 · derivative.exercise_date: The shares vest 25% on the first anniversary of the first day of the month following the Grant Date, with the remainder to vest at the rate of 1/36 per month thereafter. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 22:04 UTC |
Marban LindaDirector · CHIEF EXECUTIVE OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 458,693 | $0.00 Strike: $3.74 | $0.00 |
DisclosureSEC source: 0001104659-21-001595 · tm211849-8_4seq1.xml · derivative · entry 1 Marban Linda · CIK 0001593084 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 458,693 Underlying: Common Stock · 458,693 shares Expires 2031-01-04 F1 · derivative.exercise_date: The shares vest 1/48th of the first day of each month, commencing February 1, 2021, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 22:04 UTC |
Manzo LouisDirector
|
GrantStock Option (Right to Buy) · Derivative | 72,066 | $0.00 Strike: $3.74 | $0.00 |
DisclosureSEC source: 0001104659-21-001593 · tm211849-7_4seq1.xml · derivative · entry 1 Manzo Louis · CIK 0001593100 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,066 Underlying: Common Stock · 72,066 shares Expires 2031-01-04 F1 · derivative.exercise_date: The shares vest 1/48th of the first day of each month, commencing February 1, 2021, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 22:03 UTC |
Litvack FrankDirector
|
GrantStock Option (Right to Buy) · Derivative | 211,160 | $0.00 Strike: $3.74 | $0.00 |
DisclosureSEC source: 0001104659-21-001586 · tm211849-4_4seq1.xml · derivative · entry 1 Litvack Frank · CIK 0001310715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,160 Underlying: Common Stock · 211,160 shares Expires 2031-01-04 F1 · derivative.exercise_date: The shares vest 1/48th of the first day of each month, commencing February 1, 2021, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 22:03 UTC |
DUNBAR GEORGE W JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 71,388 | $0.00 Strike: $3.74 | $0.00 |
DisclosureSEC source: 0001104659-21-001588 · tm211849-5_4seq1.xml · derivative · entry 1 DUNBAR GEORGE W JR · CIK 0001194712 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,388 Underlying: Common Stock · 71,388 shares Expires 2031-01-04 F1 · derivative.exercise_date: The shares vest 1/48th of the first day of each month, commencing February 1, 2021, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 22:04 UTC |
Krasney KarenEVP, GENERAL COUNSEL
|
GrantStock Option (Right to Buy) · Derivative | 95,693 | $0.00 Strike: $3.74 | $0.00 |
DisclosureSEC source: 0001104659-21-001590 · tm211849-6_4seq1.xml · derivative · entry 1 Krasney Karen · CIK 0001593086 · EVP, GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,693 Underlying: Common Stock · 95,693 shares Expires 2031-01-04 F1 · derivative.exercise_date: The shares vest 1/48th of the first day of each month, commencing February 1, 2021, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 22:03 UTC |
COLLIER EARL M JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 71,951 | $0.00 Strike: $3.74 | $0.00 |
DisclosureSEC source: 0001104659-21-001584 · tm211849-3_4seq1.xml · derivative · entry 1 COLLIER EARL M JR · CIK 0001201254 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,951 Underlying: Common Stock · 71,951 shares Expires 2031-01-04 F1 · derivative.exercise_date: The shares vest 1/48th of the first day of each month, commencing February 1, 2021, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 22:02 UTC |
Musket David BDirector
|
GrantStock Option (Right to Buy) · Derivative | 96,126 | $0.00 Strike: $3.74 | $0.00 |
DisclosureSEC source: 0001104659-21-001583 · tm211849-2_4seq1.xml · derivative · entry 1 Musket David B · CIK 0001310611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,126 Underlying: Common Stock · 96,126 shares Expires 2031-01-04 F1 · derivative.exercise_date: The shares vest 1/48th of the first day of each month, commencing February 1, 2021, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.